A5025767180- High-Velocity Impact and Material Behavior
- Microstructure and mechanical properties
- Aluminum Alloys Composites Properties
- Cardiomyopathy and Myosin Studies
- Magnesium Alloys: Properties and Applications
- Hepatitis C virus research
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- Muscle Physiology and Disorders
- Dermatological and Skeletal Disorders
- Inflammatory Myopathies and Dermatomyositis
- Metallurgy and Material Forming
- Caveolin-1 and cellular processes
- High-pressure geophysics and materials
- Microstructure and Mechanical Properties of Steels
- Energetic Materials and Combustion
- Advanced ceramic materials synthesis
- RNA Research and Splicing
- Structural Response to Dynamic Loads
- Ultrasonics and Acoustic Wave Propagation
- Optical measurement and interference techniques
- Electromagnetic Launch and Propulsion Technology
- Metal and Thin Film Mechanics
- Metal Forming Simulation Techniques
- Planetary Science and Exploration
Bankstown Lidcombe Hospital
2006-2024
DEVCOM Army Research Laboratory
2015-2024
United States Army Combat Capabilities Development Command
2021-2024
Fibertek (United States)
2023
University of Maryland, Baltimore County
2009-2014
Lister Hospital
2009
Hy-Line (United States)
2006
Edith Cowan University
1993-2004
Royal Perth Hospital
2004
The University of Western Australia
1999-2002
Current guidelines recommend long-term nucleot(s)ide analogue (NA) therapy for patients with HBeAg-negative chronic hepatitis B (CHB). However, disease remission has been described after stopping NA therapy, as well HBsAg loss.We performed a prospective multi-centre cohort study of therapy. Inclusion criteria were CHB, the absence cirrhosis and HBVDNA<lower limit quantification ≥18 months. We assessed virological biochemical outcomes including loss, restart rates, over 96 weeks.In total, 110...
Background and Aims: HBV RNA in peripheral blood reflects cccDNA transcriptional activity may predict clinical outcomes. The prospective Melbourne HBV-STOP trial studied nucleot(s)ide analog discontinuation HBeAg-negative non-cirrhotic participants with long-term virological suppression. Ninety-six weeks after stopping treatment, the proportion of relapse (HBV DNA > 2000 IU/mL), biochemical (ALT 2 × ULN or hepatitis flare 5 IU/mL) was 89%, 58%, 38%, respectively. We evaluated ability...
Accurate biomarkers to predict outcomes following discontinuation of nucleos(t)ide analogue (NA) therapy are needed. We evaluated serum hepatitis B core-related antigen (HBcrAg) level as a biomarker for predicting after NA discontinuation.
Conventional Split Hopkinson Pressure Bars (SHPB) or “Kolsky” bars are often used for determining the high-rate compressive yield and failure strength of materials. However, experiments generating very high strain-rates (>103/s) miniaturization setup is required minimizing effects elastic wave dispersion in order to enable inference decreasingly short loading events from data. Miniature aluminum steel sufficient meeting these requirements. enough strain-rates, Kolsky may require...